Ignite Creation Date:
2025-12-25 @ 3:16 AM
Ignite Modification Date:
2026-01-06 @ 12:58 AM
Study NCT ID:
NCT02285205
Status:
COMPLETED
Last Update Posted:
2016-02-02
First Post:
2014-11-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A 24 Week, Multicenter, Prospective, Open-labeled, Single-arm, Exploratory Phase 4 Clinical Trial to Evaluate the Safety and Efficacy of Lobeglitazone in Decreasing Intrahepatic Fat Contents in Type 2 Diabetes With NAFLD
Sponsor:
Yonsei University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-11
Start Date Type:
None
Primary Completion Date:
2015-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-11
Completion Date Type:
ACTUAL
First Submit Date:
2014-11-04
First Submit QC Date:
None
Study First Post Date:
2014-11-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-01-31
Last Update Post Date:
2016-02-02
Last Update Post Date Type:
ESTIMATED